In four of the studies there was a slightly increased rate of hypoglycemia episodes in the combination with DPP-4 inhibitor and sulfonylura compared to sulfonylurea alone (78, 79, 81, 82). This evidence concerns the gene DPP4 and Hypoglycemia.